General and Plastic Surgery Devices Panel
This article was originally published in The Gray Sheet
Executive Summary
Premarket approval application for Lifecore Biomedical's Intergel absorbable adhesion barrier device is slated to be reviewed at Jan. 12 panel meeting from 10:30 a.m. to 5:00 p.m. at FDA's Corporate Building in Rockville, Maryland